ELAFIBRANORSELADELPAROBETICHOLIC ACIDELFursodeoxycholic acidSELOCAUDCAprimary biliary cholangitisPBC
…% CI 23.7 – 50.3)) SELADELPAR (ARR = 40.9 (95% CI 28.1 – 53.8)) ELAFIBRANOR (ARR = 47.2 (95% CI 36.4 – 57.9)) ARR = 10.2 (-6.9 ; 27,3) p = …
10articles mentioning drugs
12drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Obeticholic Acid ×
Obeticholic Acid
This drug is selected. Its supporting articles are shown below.
Articles mentioning Obeticholic Acid
10 articles · page 1 of 1elafibranorbezafibrate
…afibranor initiation. 2 (7.4%) patients continued OCA alongside elafibranor. 19 (70.4%) patients had trialled bezafibrate prior to elafibra…
ursodeoxycholic acidobeticholic acidMaralixibatfibroblast growth factor 19 (FGF19) analoguesFGF19 analoguesapical sodium-dependent bile acid transporter (ASBT) inhibitorsPBCintrahepatic cholestasisMDR3 deficiencyprimary biliary cholangitis (PBC)+3 more
…lusions Mdr2-/- mice show a limited response to BAAs (including ursodeoxycholic acid), consistent with humans who have severe loss-of-function ABCB4…
bezafibrateElafibranorElaBZFUDCAOCA
…UDCA), obeticholic acid (OCA), and amongst those switching from bezafibrate (BZF).Results From Dec 2024 to Nov 2025, 54 pts initiated Ela (…
SeladelparUDCAfenofibrateelafibranorObeticholic acidursodeoxycholic acid (UDCA)OCASEL-2LOCA-switchPrimary biliary cholangitis (PBC)
… was recently withdrawn from the US creating a therapeutic gap. Seladelpar (SEL), approved in 2024 in the US for patients with PBC and an …
BezafibrateObeticholic acidUrsodeoxycholic acidSeladelparElafibranorUDCAPrimary Biliary CholangitisPBC
…py, while 27% were prescribed second-line treatments, including Bezafibrate (31 patients), Obeticholic acid (20 patients), and Elafibranor …
OCA-FIBfibrateUDCAObeticholic acidFIB-OCAbezafibrateOCAprimary biliary cholangitisPBC
…le therapies Fibrate therapy First (FIB-OCA) OCA therapy First (OCA-FIB) (FIB-OCA) and (OCA-FIB) Comparative p Values ALP M0 (n27) M6 (…
BezafibrateObeticholic acidUDCABZAUrsodeoxycholic acidOCAPrimary biliary cholangitisBarts Health NHS Trust
…cribed Ursodeoxycholic acid (UDCA), Obeticholic acid (OCA), and Bezafibrate (BZA), has shown biochemical benefit in patients with inadequat…
Obeticholic acidbezafibrateursodeoxycholic acidUDCAprimary biliary cholangitisOffice for National StatisticsSLTThe Royal London Hospital hub centreUK tertiary hepatology centre
…43%) and Caucasian (39%) patients than in Asian patients (26%). Obeticholic acid was more widely prescribed than bezafibrate in all groups. Asia…
Ursodeoxycholic acid (UDCA)Obeticholic AcidObeticholic Acid (OCA)UDCAPrimary Biliary Cholangitis (PBC)Newcastle-upon-Tyne Hospitals Trustnephrotic syndromePBCcirrhosis
…Aim Ursodeoxycholic acid (UDCA) is the licensed 1st-line therapy for Primary Biliary Cholangiti…